Agricultural Residues as Pharmaceutical Excipient

Authors

  • Bhupinder Singh Sekhon PCTE Institute of Pharmacy, Ludhiana, Punjab, India

DOI:

https://doi.org/10.37591/(rrjops).v5i3.526

Abstract

 

Excipients development has become a core area of research in pharmaceutical drug delivery. Agricultural residues and natural sources represent a potential source of inexpensive pharmaceutical excipients. Pharmaceutical excipients have vital roles in drug formulations and dosage forms and are used as thickeners, gelling, bulking and water retention agents, fillers, binders, disintegrants, lubricant and/or glidant, flavours and sweeteners. Microcrystalline cellulose (MCC), a very important directly compressible excipient widely used in pharmaceutical formulations has been prepared from various agricultural residues and compared with commercial MCC. Conversion of agricultural residues into pharmaceutical excipients will prevent pollution and also become economically profitable for farmers. To meet pharmacopoeial standards, a complete development of pharmqaceutical excipients from agricultural residues is desired.

 

Keywords: Pharmaceutical excipients, natural polymers, Microcrystalline cellulose, solid dosage forms, tropical plants, agricultural residues

 

Downloads

Published

2019-07-11

Issue

Vol. 5 No. 3 (2014)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.